Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Montgomery

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Gerontology|October 24, 2002
Late-life depression: rationalizing pharmacological treatment optionsStuart A Montgomery
International Clinical Psychopharmacology|January 27, 2006
Why do we need new and better antidepressants?Stuart A Montgomery
CNS Spectrums|December 17, 2008
Tolerability of serotonin norepinephrine reuptake inhibitor antidepressantsStuart A Montgomery
International Clinical Psychopharmacology|February 28, 2008
The under-recognized role of dopamine in the treatment of major depressive disorderStuart A Montgomery
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Guidelines in major depressive disorder, and their limitationsStuart A Montgomery
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Evidence-based prescribing of antidepressantsStuart A Montgomery
International Clinical Psychopharmacology|April 11, 2003
Dopaminergic deficit and the role of amisulpride in the treatment of mood disordersStuart A Montgomery
Expert Opinion on Pharmacotherapy|October 6, 2006
Pregabalin for the treatment of generalised anxiety disorderStuart A Montgomery
International Clinical Psychopharmacology|August 11, 2007
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatineStuart A Montgomery, Siegfried Kasper
International Clinical Psychopharmacology|April 10, 2009
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?Stuart A Montgomery, Hans-Jürgen Möller
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Gerontology|October 24, 2002
Late-life depression: rationalizing pharmacological treatment optionsStuart A Montgomery
International Clinical Psychopharmacology|January 27, 2006
Why do we need new and better antidepressants?Stuart A Montgomery
CNS Spectrums|December 17, 2008
Tolerability of serotonin norepinephrine reuptake inhibitor antidepressantsStuart A Montgomery
International Clinical Psychopharmacology|February 28, 2008
The under-recognized role of dopamine in the treatment of major depressive disorderStuart A Montgomery
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Guidelines in major depressive disorder, and their limitationsStuart A Montgomery
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Evidence-based prescribing of antidepressantsStuart A Montgomery
International Clinical Psychopharmacology|April 11, 2003
Dopaminergic deficit and the role of amisulpride in the treatment of mood disordersStuart A Montgomery
Expert Opinion on Pharmacotherapy|October 6, 2006
Pregabalin for the treatment of generalised anxiety disorderStuart A Montgomery
International Clinical Psychopharmacology|August 11, 2007
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatineStuart A Montgomery, Siegfried Kasper
International Clinical Psychopharmacology|April 10, 2009
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?Stuart A Montgomery, Hans-Jürgen Möller
Pageof 5